Correlation Between VanEck Pharmaceutical and Invesco SP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VanEck Pharmaceutical and Invesco SP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VanEck Pharmaceutical and Invesco SP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VanEck Pharmaceutical ETF and Invesco SP SmallCap, you can compare the effects of market volatilities on VanEck Pharmaceutical and Invesco SP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VanEck Pharmaceutical with a short position of Invesco SP. Check out your portfolio center. Please also check ongoing floating volatility patterns of VanEck Pharmaceutical and Invesco SP.

Diversification Opportunities for VanEck Pharmaceutical and Invesco SP

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between VanEck and Invesco is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Pharmaceutical ETF and Invesco SP SmallCap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco SP SmallCap and VanEck Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VanEck Pharmaceutical ETF are associated (or correlated) with Invesco SP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco SP SmallCap has no effect on the direction of VanEck Pharmaceutical i.e., VanEck Pharmaceutical and Invesco SP go up and down completely randomly.

Pair Corralation between VanEck Pharmaceutical and Invesco SP

Considering the 90-day investment horizon VanEck Pharmaceutical ETF is expected to under-perform the Invesco SP. But the etf apears to be less risky and, when comparing its historical volatility, VanEck Pharmaceutical ETF is 1.65 times less risky than Invesco SP. The etf trades about -0.19 of its potential returns per unit of risk. The Invesco SP SmallCap is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  10,728  in Invesco SP SmallCap on August 29, 2024 and sell it today you would earn a total of  843.00  from holding Invesco SP SmallCap or generate 7.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

VanEck Pharmaceutical ETF  vs.  Invesco SP SmallCap

 Performance 
       Timeline  
VanEck Pharmaceutical ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.
Invesco SP SmallCap 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco SP SmallCap are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Invesco SP may actually be approaching a critical reversion point that can send shares even higher in December 2024.

VanEck Pharmaceutical and Invesco SP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VanEck Pharmaceutical and Invesco SP

The main advantage of trading using opposite VanEck Pharmaceutical and Invesco SP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VanEck Pharmaceutical position performs unexpectedly, Invesco SP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco SP will offset losses from the drop in Invesco SP's long position.
The idea behind VanEck Pharmaceutical ETF and Invesco SP SmallCap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges